Oren Shuster, CEO of IM Cannabis Corp., joined Barrington Miller in the podcast studio to share how the company’s foundation has been built on the experience of growing pharma-grade cannabis since 2010 (3:21), their focus on applying EU GMP standards to meet growing demand in Europe (5:13), and the important lessons learned through trial and error over the years (8:12). Listen until the end to learn more about the distinct differences between the EU/Israeli market vis-à-vis North America and the opportunity presented by the German medical cannabis market.